This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory, Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zhixiang Pan: Innovator in Medicinal Chemistry
Introduction
Zhixiang Pan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways. His work is essential for advancing therapeutic options for diseases associated with abnormal kinase expression.
Latest Patents
Zhixiang Pan holds 1 patent for a compound having a KHK inhibitory effect. This patent describes a compound or its pharmaceutically acceptable salts that can be used in the preparation of a medicament for treating diseases linked to KHK kinase abnormal expression. The compound is represented by a specific formula, which highlights its potential utility in medical applications.
Career Highlights
Zhixiang Pan is currently employed at Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. His role at the company allows him to engage in innovative research and development, contributing to the advancement of pharmaceutical products. His expertise in medicinal chemistry has positioned him as a valuable asset in the industry.
Collaborations
Zhixiang Pan has collaborated with notable colleagues, including Haiying He and Zhigan Jiang. These partnerships enhance the research environment and foster innovation within the pharmaceutical sector.
Conclusion
Zhixiang Pan's work exemplifies the impact of innovative research in medicinal chemistry. His contributions are paving the way for new therapeutic solutions, demonstrating the importance of continued exploration in this vital field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile